US pharma company fined 435 million dollars.
McLaughlin
Paul
P
D000329:Advertising; D000970:Antineoplastic Agents / Q000191:economics; D035881:Compensation and Redress; D017277:Drug Approval; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D006801:Humans; D014481:United States
D000970:Antineoplastic Agents